Approval · Notice of Compliance 34195 · 2024
VIBERZI: Notice of Compliance 34195
Issued October 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34195
- Date
- October 15, 2024
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a manufacturing site and/or manufacture r involving production of the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIBERZI | Not yet assigned | — |
Medicinal ingredients
- ELUXADOLINE 75 MG per TAB
- ELUXADOLINE 100 MG per TAB